Kailiang Zhou
Impact in
-
- Spinal Cord Injury Research
- Spine and Intervertebral Disc Pathology
- Rehabilitation top 2%
- Wound Healing and Treatments
Papers in
-
- Inflammasome and immune disorders 20
- Extracellular vesicles in disease 7
- Cell death mechanisms and regulation 5
- Epidemiology 31
- Autophagy in Disease and Therapy 29
- Co-authors
- Huazi Xu (28 shared papers)Jian Xiao (29 shared papers)Haojie Zhang (19 shared papers)Xinli Hu (16 shared papers)Huanwen Chen (12 shared papers)Xiangyang Wang (22 shared papers)Chang Jia (8 shared papers)Yao Li (15 shared papers)
- Journals
- International Immunopharmacology (5 papers)Oxidative Medicine and Cellular Longevity (5 papers)Drug Design Development and Therapy (4 papers)Cell Death and Disease (4 papers)Molecular Neurobiology (3 papers)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Kailiang Zhou
85 papers receiving 3.4k citations
Kailiang Zhou's Hit Papers
Peers
Comparison fields: 5 of 113
- Pathology and Forensic Medicine 796
- Rehabilitation 169
- Molecular Biology 1.6k
- Neurology 176
- Epidemiology 624
Countries citing papers authored by Kailiang Zhou
This map shows the geographic impact of Kailiang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kailiang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kailiang Zhou more than expected).
Fields of papers citing papers by Kailiang Zhou
This network shows the impact of papers produced by Kailiang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kailiang Zhou. The network helps show where Kailiang Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Kailiang Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 279 | |
| 2 | 2019 | 220 | |
| 3 | 2018 | 205 | |
| 4 | Emerging role of STING signalling in CNS injury: inflammation, autophagy, necroptosis, ferroptosis and pyroptosis Hit paper breakdown → | 2022 | 191 |
| 5 | 2020 | 181 | |
| 6 | Betulinic acid inhibits pyroptosis in spinal cord injury by augmenting autophagy via the AMPK-mTOR-TFEB signaling pathway Hit paper breakdown → | 2021 | 148 |
| 7 | 2020 | 134 | |
| 8 | 2020 | 91 | |
| 9 | 2015 | 80 | |
| 10 | 2020 | 79 | |
| 11 | 2021 | 78 | |
| 12 | 2016 | 72 | |
| 13 | 2020 | 69 | |
| 14 | 2017 | 64 | |
| 15 | 2023 | 60 | |
| 16 | 2019 | 56 | |
| 17 | 2022 | 54 | |
| 18 | 2019 | 53 | |
| 19 | 2021 | 52 | |
| 20 | 2019 | 50 |
About Kailiang Zhou
Kailiang Zhou is a scholar working on Molecular Biology, Epidemiology, Pathology and Forensic Medicine, Surgery and Rehabilitation, having authored 89 papers that have together received 3.5k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (29 papers), Spinal Cord Injury Research (21 papers), Inflammasome and immune disorders (20 papers), Wound Healing and Treatments (9 papers), Extracellular vesicles in disease (7 papers), Toxoplasma gondii Research Studies (6 papers), Nerve injury and regeneration (5 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (796 citations), Rehabilitation (169 citations), Molecular Biology (1.6k citations), Neurology (176 citations) and Epidemiology (624 citations). Kailiang Zhou has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Huazi Xu, Jian Xiao, Haojie Zhang, Xinli Hu, Huanwen Chen, Xiangyang Wang, Chang Jia, Yao Li, Weiyang Gao and Yanqing Wu. Their work appears in journals such as International Immunopharmacology, Oxidative Medicine and Cellular Longevity, Drug Design Development and Therapy, Cell Death and Disease and Molecular Neurobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.